These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17622926)

  • 21. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes.
    Kress DC; Aronson S; McDonald ML; Malik MI; Divgi AB; Tector AJ; Downey FX; Anderson AJ; Stone M; Clancy C
    Ann Thorac Surg; 2007 May; 83(5):1737-43. PubMed ID: 17462391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
    Shoenfeld Y
    Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 28. Uncomplicated heparinization for cardiopulmonary bypass in a patient with antiheparin antibodies.
    Morewood GH
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):309-11. PubMed ID: 10890487
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypothermic cardiopulmonary bypass as a determinant of late thrombocytopenia following cardiac operations in pediatric patients.
    Ranucci M; Carlucci C; Isgrò G; Brozzi S; Boncilli A; Costa E; Frigiola A
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1060-7. PubMed ID: 19496765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 31. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.
    Pötzsch B; Klövekorn WP; Madlener K
    N Engl J Med; 2000 Aug; 343(7):515. PubMed ID: 10950681
    [No Abstract]   [Full Text] [Related]  

  • 33. Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
    Boshkov LK; Kirby A; Shen I; Ungerleider RM
    Ann Thorac Surg; 2006 Jun; 81(6):S2355-9. PubMed ID: 16731103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 35. Delayed-onset heparin-induced thrombocytopenia and thrombosis.
    Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575
    [No Abstract]   [Full Text] [Related]  

  • 36. Temporal aspects of anti-heparin-PF4 antibodies in heparin-induced thrombocytopenia.
    Newall F; Ignjatovic V; Monagle P
    Ann Thorac Surg; 2006 May; 81(5):1944; author reply 1944-5. PubMed ID: 16631722
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
    Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
    Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
    Warkentin TE; Greinacher A; Koster A
    Ann Thorac Surg; 2009 May; 87(5):1633-40. PubMed ID: 19379937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
    Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM
    Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.